logo
logo
Sign in

Genetic Testing Market is Estimated to Witness High Growth Owing to Increasing Consumer Awareness

avatar
Saya Bonde
Genetic Testing Market is Estimated to Witness High Growth Owing to Increasing Consumer Awareness

The genetic testing market involves analyzing human DNA sequences in order to determine a person's ancestry, detect genetic diseases or predict their risk of developing certain health conditions. Genetic testing enables early disease detection and diagnosis, and helps in determining appropriate treatments. It is an important part of personalized medicine and plays a key role in disease management and drug development. Growing awareness about genetic testing services and declining prices coupled with rising demand for personalized treatment are some of the major factors driving the market growth.

The Global genetic testing market is estimated to be valued at US$ 18.24 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the genetic testing market include 23&Me Inc., Qiagen NV, Eurofins Scientific, PerkinElmer Inc., Illumina Inc., Danaher Corporation, Myriad Genetics Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, BioRad Laboratories Inc., and DiaSorin S.p.A. (Luminex Corporation), among others. These players are focusing on expanding their product portfolios and service offerings through acquisitions and partnerships.

The market offers significant growth opportunities in terms of direct-to-consumer genetic testing services and pharmacogenomic testing. Continuous advancements in sequencing technologies and declining testing prices are further expected to drive adoption rates.

Globally, North America dominates the genetic testing market owing to technological advancements, growing awareness, strong government support and rising disease burden. However, Asia Pacific is expected grow at the fastest rate over the forecast period supported by increasing healthcare expenditure, large patient pool and initiatives taken by market participants.

Market Drivers

Increasing awareness about the importance of genetic testing among consumers is a key growth driver. Earlier people were not fully aware about the benefits and applications of genetic testing. However, with growing literacy rates and health campaigns, consumers are now more informed about genetic conditions, disease risk factors and test reliability. This has boosted demand for genetic screening and diagnostic testing.

Medical simplification owing to genetic data is another major market driver. Genetic information helps physicians understand disease pathology at molecular level and determine best treatment strategies. It facilitates streamlined diagnosis and aids drug development process. Thus genetic testing is gaining recognition as an integral part of precision medicine approach which examines individual patient characteristics.

PEST Analysis

Political: The genetic testing market is regulated by various government bodies worldwide and regulatory policies play a major role in shaping the overall demand and supply dynamics. Changes in regulations regarding data privacy and usage of genetic information impacts the market.

Economic: Economic growth leads to higher spending on healthcare and wellness. Growing affordability influences consumer spending on genetic testing for various health and ancestry applications.

Social: Increased awareness about genetic profiling and risk assessment drives demand. People are more open to knowing their genetic makeup for predicting health risks and taking preventive measures. Social stigmas towards certain genetic disorders also influence testing decisions.

Technological: Advanced technologies like next-generation sequencing and rapid DNA analysis have made tests more affordable and accessible. Innovations facilitate comprehensive screening of entire human genomes in short durations enabling clinical and research applications. Wearable biosensors and portable devices also aid decentralized community healthcare using genetic data.

Geographical concentration

North America currently accounts for the largest share of the global genetic testing market, primarily led by the United States. Robust healthcare infrastructure, rising incidence of chronic diseases, growing geriatric population susceptible to genetic disorders, and increasing consumer awareness drive the regional market.

Fastest growing region

Asia Pacific is poised to be the fastest growing regional market over the forecast period supported by factors such as rising healthcare expenditure, increasing population with genetic health risks, expanding medical tourism industry and entry of global market players. Growing middle-class populations in countries like China, India and Japan offer significant growth opportunities.

collect
0
avatar
Saya Bonde
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more